AAAAAA
Results: 1-25/72
Authors:
WALLACE RW
Citation: Rw. Wallace, OPPORTUNITY NOT EXPLOITATION - VALUING THE ICELANDIC GENOME, Drug discovery today, 3(8), 1998, pp. 355-357
Authors:
WALLACE RW
Citation: Rw. Wallace, A LITTLE TOO MUCH - EXPENSE VERSUS RETURN IN HTS MINIATURIZATION, Drug discovery today, 3(7), 1998, pp. 299-299
Authors:
WALLACE RW
Citation: Rw. Wallace, DIVERSA AND DIVERSITY, Drug discovery today, 3(6), 1998, pp. 246-247
Authors:
WALLACE RW
Citation: Rw. Wallace, DIRECTED CANCER DRUGS, Drug discovery today, 3(4), 1998, pp. 147-147
Authors:
WALLACE RW
Citation: Rw. Wallace, HIGH-THROUGHPUT SCREENING - ACCESSIBLE UHTS, Drug discovery today, 3(4), 1998, pp. 192-192
Authors:
WALLACE RW
Citation: Rw. Wallace, CANCER STOPS AT RED-LIGHT, Drug discovery today, 3(2), 1998, pp. 47-48
Authors:
WALLACE RW
Citation: Rw. Wallace, HIGH-THROUGHPUT SCREENING, Drug discovery today, 3(2), 1998, pp. 92-93
Authors:
WALLACE RW
Citation: Rw. Wallace, MEDIA HYPE AND DRUG DISCOVERY, Drug discovery today, 3(10), 1998, pp. 433-434
Authors:
WALLACE RW
Citation: Rw. Wallace, RATIONAL THERAPEUTICS, Drug discovery today, 3(1), 1998, pp. 4-5
Authors:
WALLACE RW
Citation: Rw. Wallace, THE HUMAN GENOME DIVERSITY PROJECT - MEDICAL BENEFITS VERSUS ETHICAL CONCERNS, Molecular medicine today, 4(2), 1998, pp. 59-62
Authors:
BELLINDER RR
ARSENOVIC M
KIRKWYLAND JJ
WALLACE RW
Citation: Rr. Bellinder et al., EVALUATING THE EPAS COMPARATIVE PRODUCT PERFORMANCE TESTING GUIDELINES FOR HERBICIDES IN SNAP BEAN (PHASEOLUS-VULGARIS), Weed technology, 12(2), 1998, pp. 215-222
Authors:
BOSENBERG WR
ALEXANDER JI
MYERS LE
WALLACE RW
Citation: Wr. Bosenberg et al., 2.5-W, CONTINUOUS-WAVE, 629-NM SOLID-STATE LASER SOURCE, Optics letters, 23(3), 1998, pp. 207-209
Authors:
WALLACE RW
Citation: Rw. Wallace, WHATS YOUR POISON, Drug discovery today, 2(9), 1997, pp. 359-361
Authors:
WALLACE RW
Citation: Rw. Wallace, EMERGING MOLECULAR TARGETS, Drug discovery today, 2(9), 1997, pp. 396-396
Authors:
WALLACE RW
Citation: Rw. Wallace, EMERGING MOLECULAR TARGETS - TARGETING TYROSINE KINASES, Drug discovery today, 2(8), 1997, pp. 355-355
Authors:
WALLACE RW
Citation: Rw. Wallace, HIGH-THROUGHPUT SCREENING - 1536-WELL PLATES AT PHARMACOPEIA, Drug discovery today, 2(8), 1997, pp. 355-355
Authors:
WALLACE RW
Citation: Rw. Wallace, EMERGING MOLECULAR TARGETS, Drug discovery today, 2(7), 1997, pp. 305-305
Authors:
WALLACE RW
Citation: Rw. Wallace, TOWARD EFFECTIVE CF TREATMENT, Drug discovery today, 2(6), 1997, pp. 212-212
Authors:
WALLACE RW
Citation: Rw. Wallace, EMERGING MOLECULAR TARGETS, Drug discovery today, 2(6), 1997, pp. 250-250
Authors:
WALLACE RW
Citation: Rw. Wallace, EMERGING MOLECULAR TARGETS, Drug discovery today, 2(5), 1997, pp. 207-207
Authors:
WALLACE RW
Citation: Rw. Wallace, P53 TUMOR-SUPPRESSOR AND CELL-GROWTH, Drug discovery today, 2(4), 1997, pp. 164-164
Authors:
WALLACE RW
Citation: Rw. Wallace, NEW HIV PROTEASE INHIBITORS, Drug discovery today, 2(3), 1997, pp. 83-84
Authors:
WALLACE RW
Citation: Rw. Wallace, EMERGING MOLECULAR TARGETS - CELL-PERMEABLE PEPTIDE IMPORT FOR USE INTARGET VALIDATION, Drug discovery today, 2(3), 1997, pp. 124-125
Authors:
WALLACE RW
Citation: Rw. Wallace, EMERGING MOLECULAR TARGETS, Drug discovery today, 2(2), 1997, pp. 82-82
Authors:
WALLACE RW
Citation: Rw. Wallace, COMBINATORIAL BIOSYNTHESIS, Drug discovery today, 2(12), 1997, pp. 505-506